Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Betts

Showing results (311-320 of 317) with videos related to

Pageof 32
Sort By:
You have reached the last page of results.This site can display upto 317 results.
European Urology Oncology|February 26, 2023
A Matching-adjusted Indirect Comparison of Nivolumab Plus Cabozantinib Versus Pembrolizumab Plus Axitinib in Patients with Advanced Renal Cell CarcinomaBradley McGregor, Daniel M Geynisman, Mauricio Burotto, et al.
Life Science Alliance|August 14, 2021
Dystrophin involvement in peripheral circadian SRF signallingCorinne A Betts, Aarti Jagannath, Tirsa LE van Westering, et al.
Cell Reports. Medicine|August 6, 2024
Ketogenic diet but not free-sugar restriction alters glucose tolerance, lipid metabolism, peripheral tissue phenotype, and gut microbiome: RCTAaron Hengist, Russell G Davies, Jean-Philippe Walhin, et al.
Nature|February 15, 2024
Critical transitions in the Amazon forest systemBernardo M Flores, Encarni Montoya, Boris Sakschewski, et al.
American Journal of Human Genetics|August 5, 2017
Long Noncoding RNAs CUPID1 and CUPID2 Mediate Breast Cancer Risk at 11q13 by Modulating the Response to DNA DamageJoshua A Betts, Mahdi Moradi Marjaneh, Fares Al-Ejeh, et al.
American Journal of Human Genetics|December 23, 2014
Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1Dylan M Glubb, Mel J Maranian, Kyriaki Michailidou, et al.
American Journal of Human Genetics|April 2, 2013
Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancersJuliet D French, Maya Ghoussaini, Stacey L Edwards, et al.
Pageof 32

Showing results (311-320 of 317) with videos related to

Sort By:
Pageof 32
You have reached the last page of results.This site can display upto 317 results.
European Urology Oncology|February 26, 2023
A Matching-adjusted Indirect Comparison of Nivolumab Plus Cabozantinib Versus Pembrolizumab Plus Axitinib in Patients with Advanced Renal Cell CarcinomaBradley McGregor, Daniel M Geynisman, Mauricio Burotto, et al.
Life Science Alliance|August 14, 2021
Dystrophin involvement in peripheral circadian SRF signallingCorinne A Betts, Aarti Jagannath, Tirsa LE van Westering, et al.
Cell Reports. Medicine|August 6, 2024
Ketogenic diet but not free-sugar restriction alters glucose tolerance, lipid metabolism, peripheral tissue phenotype, and gut microbiome: RCTAaron Hengist, Russell G Davies, Jean-Philippe Walhin, et al.
Nature|February 15, 2024
Critical transitions in the Amazon forest systemBernardo M Flores, Encarni Montoya, Boris Sakschewski, et al.
American Journal of Human Genetics|August 5, 2017
Long Noncoding RNAs CUPID1 and CUPID2 Mediate Breast Cancer Risk at 11q13 by Modulating the Response to DNA DamageJoshua A Betts, Mahdi Moradi Marjaneh, Fares Al-Ejeh, et al.
American Journal of Human Genetics|December 23, 2014
Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1Dylan M Glubb, Mel J Maranian, Kyriaki Michailidou, et al.
American Journal of Human Genetics|April 2, 2013
Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancersJuliet D French, Maya Ghoussaini, Stacey L Edwards, et al.
Pageof 32